Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hyoscine on labor progress and pregnancy outcome
PACTR202407805328722Phase 4Not yet recruiting
- Sponsor
- Rahmat Adamu
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hyoscine butylbromide in childbirth (2 arms), sponsored by Rahmat Adamu. Primary endpoints: Duration of first stage of labor, Duration of second stage of labor and 4 more. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
childbirth
Beyond the preview
Go deeper on PACTR202407805328722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407805328722.